Company intelligence / Profile preview

Cytec Industries

Princeton, New Jersey, USAcytec-ate.com ↗

Ownership: Private
Employees: ~6600
Development stage: Other

Overview

Cytec Industries was a global leader in specialty chemicals and advanced materials, supplying high-performance products for aerospace, automotive, industrial, mining, and healthcare sectors. In pharmaceuticals and healthcare, it was best known for manufacturing Docusate sodium (DSS), a key pharmaceutical-grade surfactant/excipient. The company did not develop therapeutic drugs but provided critical ingredients used by drug manufacturers. In December 2015 it was acquired by Solvay for $5.5 billion.

Industry: Chemicals & Materials

Partnerships

Mubadala Development CompanyPenso Holdings

Beyond the preview

Go deeper on Cytec Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytec Industries.

Explore the full profile